Delivery Order SPE2DE22D0008-SPE2D625F0JKY
Award Date 8/6/25
Potential Completion Date 10/9/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,115.79 to Alba Bioscience, Inc. for the ALBACYTE Antibody ID Panel (16-Cell) on October 30, 2025, with an ultimate completion date of January 7, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier of immunohematology reagents and blood banking diagnostic materials. Alba Bioscience, a...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded Alba Bioscience, Inc. a $9,500 delivery order on October 30, 2025, for an ALBACYTE Antibody ID Panel (10-Cell) with a completion date of January 7, 2026. This firm fixed-price delivery order represents a competitive procurement without set-aside designation, leveraging Alba Bioscience's specialized capabilities in immunohematology reagents and blood banking diagnostics. Alba Bioscience, a Chicago-based subsidiary of...
- Alba Bioscience, Inc. was awarded a delivery order valued at $6,270 on September 4, 2025, for the ALBACYTE Antibody ID Panel (10-Cell) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The contract is scheduled for completion by November 7, 2025, and will be performed at the contractor's facility in Chicago, Illinois. This non-set-aside award represents Alba Bioscience's continued role as a critical supplier of specialized in vitro diagnostic...
- Alba Bioscience, Inc., a Chicago-based diagnostic supplier specializing in immunohematology reagents and blood banking materials, was awarded a $4,740 delivery order by the Defense Logistics Agency's Medical Supply Chain division on October 30, 2025, for ALBACLONE Anti-B monoclonal antibodies. The contract, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by November 4, 2025, and will be performed in Chicago, Illinois. This delivery order represents a...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,370.00 to Alba Bioscience, Inc. for ALBACLONE Anti-A antibodies, with performance completion targeted for August 19, 2025. This non-set-aside contract represents a firm fixed price delivery order for specialized blood banking diagnostic reagents to be delivered to Chicago, Illinois. Alba Bioscience, a foreign-owned subsidiary of Quotient Biodiagnostics, Inc., has established itself as a critical...
- Alba Bioscience, Inc. was awarded a delivery order contract on July 15, 2025, for ALBACLONE Anti-K antibodies with a firm fixed price ceiling value of $3,400. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed in Chicago, Illinois, with an ultimate completion date of July 18, 2025. This non-set-aside award recognizes Alba Bioscience's established position as a critical supplier of in vitro diagnostic reagents and blood bank products to...
- The Defense Health Agency awarded a delivery order valued at $54,873 to Alba Bioscience, Inc. on October 1, 2024, for the supply of ALBACYTE A1 cells, ALBACYTE B cells, ALBACYTE IgG sensitized cells, and ALBACYTE antibody screening products in 3-cell configurations. This firm fixed-price delivery order, which extends through September 3, 2029, will be performed in Jacksonville, Florida, and represents a non-competitive procurement based on Alba Bioscience's specialized capabilities in...
- This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the U.S. Department of Defense (Defense) to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood bank reagents. The $1,239.00 contract is for the supply of ALBACYTE antibody screening (2-cell) products, with a period of performance through August 11, 2025. Alba Bioscience, Inc. holds multiple significant federal contract Indefinite Delivery Vehicles...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,080 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-E monoclonal antibodies under a firm fixed price contract. The award, issued on October 30, 2025, with an ultimate completion date of November 4, 2025, represents a competitive procurement with no set-aside designation. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain division to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $10,683.00, is for the delivery of ALBACYTE antibody identification panels and is a firm fixed-price agreement with a completion date...